Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation-Reference-Cited by-同舟云学术

Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation

Published:2021-07-13 Issue:11 Volume:147 Page:3245-3254
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Wang Yu-Jin,Wang Qing-Wen,Yu Dong-Hu,Song Cong-Kuan,Guo Zi-Xin,Liu Xiao-Ping,Chen Chen,Yao Jie,Wang Ai-Fen,Hu Wei-Dong^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-021-03731-2.pdf

Reference48 articles.

1. Agrawal D et al (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94:513–521. https://doi.org/10.1093/jnci/94.7.513

2. Anborgh PH, Lee DJ, Stam PF, Tuck AB, Chambers AF (2018) Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer. Expert Opin Ther Targets 22:727–734. https://doi.org/10.1080/14728222.2018.1502272

3. Blasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, Donington JS (2010) Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol 28:936–941. https://doi.org/10.1200/JCO.2009.25.5711

4. Cadranel J et al (2015) Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504. Eur Respir J 46:1440–1450. https://doi.org/10.1183/13993003.02358-2014

5. Cao L et al (2020) Cryptotanshinone strengthens the effect of gefitinib against non-small cell lung cancer through inhibiting transketolase. Eur J Pharmacol 1:173647. https://doi.org/10.1016/j.ejphar.2020.173647

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

2. Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune Response;Cancers;2023-07-03